NCLT Petition Filed by BRS Capital Two Against Kalinga Hospital Ltd.
Max Healthcare Institute Limited disclosed that a petition has been filed before the National Company Law Tribunal, Cuttack Bench (NCLT), concerning Kalinga Hospital Ltd. (KHL). The litigation involves BRS Capital Two Pte. Limited, a shareholder of KHL, and other stakeholders.The petition alleges issues of oppression and mismanagement regarding the affairs of KHL. Max Healthcare Institute Limited recently completed the acquisition of approximately 58.28% of the share capital of KHL on May 18, 2026.
The dispute centers on the actions of BRS Capital Two Pte. Limited, which filed the petition before the NCLT. The tribunal heard the submissions from the parties regarding interim reliefs sought, directing all parties to file concise written submissions based on the oral arguments advanced. The matter has been reserved for orders.
The details of the litigation, including the opposing party and the nature of the dispute, are summarized below:
| Particulars | Details |
|---|---|
| Opposing Party | BRS Capital Two Pte. Limited |
| Court/Tribunal | National Company Law Tribunal, Cuttack Bench (NCLT) |
| Dispute Summary | BRS Capital Two Pte. Limited, a shareholder of Kalinga Hospital Ltd. (KHL), filed a petition before the NCLT alleging oppression and mismanagement of KHL’s affairs and seeking interim reliefs. The matter was reserved for orders, with the next hearing scheduled for July 7, 2026. |
Regarding the expected financial implications or quantum of claims, the company stated that the outcome of the petition and its impact on Max Healthcare Institute Limited cannot be anticipated at this stage.
MAXHEALTH Stock Price Movement
On Tuesday, shares of Max Healthcare Institute Limited edged higher to close at ₹1068.75, gaining 0.51% on the day. The stock settled on strong institutional buying, with the equity trading a volume of 2.10 million shares throughout the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.